The 2024 Oracle Safety Innovation Summit EMEA in Utrecht, NL, brought together an impressive, forward-thinking group of industry leaders, including Oracle customers and partners. Over two dynamic days, we covered Oracle product roadmaps and strategies, explored global regulatory trends, and discussed key topics that are shaping the future of drug safety.
Inspiring keynotes and expert panels: Featuring leading voices in safety from global pharmaceutical leaders and sessions with expert partner organizations and CROs, the summit offered deep dives into crucial topics—including AI's impact on safety, the evolving global regulatory landscape, and how to successfully migrate to the cloud.
Exclusive access to Oracle leadership: Attendees had the opportunity to exchange ideas with Oracle's safety leadership team, gaining insights into Oracle’s vision for the future of pharmacovigilance and the strategic direction of safety innovation for the Oracle Life Sciences Safety One platform (Argus, Empirica, and Safety One Intake).
Networking opportunities: : The summit facilitated invaluable connections, with attendees networking with peers, Oracle experts, and industry leaders—fostering collaborations that are set to redefine safety standards.
Oracle Safety Innovation Summit NA 2025: Interested in expanding your safety insights in North America? Request a place at our North American summit in Reston, VA.
Missed a session or want to revisit your favorite moments? Access post-summit materials, selected session presentations, and exclusive content as a member of the Oracle Safety Consortium. Join our community to keep the conversation going and stay at the forefront of safety innovation.
VP of Global Pharmacovigilance, Incyte Corp
Head of Safety Systems, BeiGene
Oracle
Bruce Palsulich, VP of Safety, Oracle
Bruce will showcase how Oracle Health has become a multiplier in accelerating delivery of AI capabilities integrated into Oracle's safety solutions, as well as discuss how organizations can get the most value out of AI. Learn how you can apply AI to safety processes and see what's next on our innovation roadmap.
Yvonne Nanciu, PV Country Head, Bayer
Patient centricity continues to be a buzzword, but what is the reality? Yvonne Nanciu of Bayer will discuss what safety leaders can do to promote a patient-centric approach in pharmacovigilance. She will share practical examples and challenges, as well as future opportunities.